(P-2049) Interim Estimates of Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Outcomes Among Medicare Enrollees with End Stage Renal Disease — United States, September – December 2023

Saturday, October 19, 2024

12:15 PM – 1:30 PM US PT

Location: Halls JK

Presenting Author(s)

Amanda B. Payne, PhD (she/her/hers)

Epidemiologist
CDC
Atlanta, Georgia, United States

SN

Shannon Novosad, MD, MPH

Medical Officer
Centers for Disease Control and Prevention, United States
RW

Ryan E. Wiegand, PhD

Centers for Disease Control and Prevention
Atlanta, Georgia, United States
MN

Morgan Najdowski, MPH

CDC
Atlanta, Georgia, United States
Danica J. Gomes, MD, MSc (she/her/hers)

Medical Officer
Centers for Disease Control and Prevention
Powder Springs, GA, United States
MW

Megan Wallace, DrPH

CDC
Atlanta, Georgia, United States
AB

Alia Bayatti, MSPH

CMS
DC, District of Columbia, United States
HS

Heng-Ming Sung, MPH

Acumen LLC
Burlingame, California, United States
YZ

Yue Zhang, MS

Acumen LLC
Burlingame, California, United States
BL

Bradley Lufkin, MPA

Acumen LLC
Burlingame, California, United States
YC

Yoganand Chillarige, MPA

Senior Research Manager
Acumen LLC
Burlingame, California, United States
Ruth Link-Gelles, PhD, MPH

Epidemiologist
Centers for Disease Control and Prevention
Atlanta, Georgia, United States